With the incidence of type 2 diabetes and its complications among young people on the increase worldwide, aggressive measures are needed to treat and prevent the disease, two diabetes experts say in the current issue (May 26) of The lancet.

GlaxoSmithKline Plc is expected to be hit with a wave of lawsuits from users of the diabetes drug Avandia, plaintiff’s lawyers said last Wednesday.

A large clinical study meant to test the heart safety of the diabetes treatment Avandia may be in jeopardy as a result of recent reports of the drug’s risks.

We have guidelines on how to mange diabetes for the outpatient and the hospital patient, but we have no guidelines for treating people in nursing homes and the results of a study showed that only 38 percent are at goal.

Stem cells taken from the umbilical cords of newborns can be engineered to produce insulin and may some day be used to treat diabetes, US and British researchers say.

Spending 500 dollars a year to improve diabetes care is a sound investment, according to one of the first studies to examine the clinical and economic impact of quality improvement on diabetes care.

Diabetic patients exhibit a higher prevalence of aspirin resistance at a dosage of 81 mg/day than do nondiabetics with coronary artery disease.

Results from a current study showed that, Valsartan reduces high sensitivity C-reactive protein (hsCRP) levels in prediabetic, hypertensive patients with metabolic syndrome.

Postprandial glucose levels play an important and often overlooked role in cardiovascular disease in type 2 diabetes patients.

In overweight patients, fish oil supplements and regular aerobic exercise reduced body fat and improved cardiovascular and metabolic health, according to the results of a new study.